Crossmark

Intravenous gadolinium-based hepatocyte-specific contrast agents (HSCAs) for contrast-enhanced liver magnetic resonance imaging in pediatric patients: what the radiologist should know

Crossref DOI link: https://doi.org/10.1007/s00247-019-04476-4

Published Online: 2019-07-26

Published Print: 2019-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ayyala, Rama S. https://orcid.org/0000-0002-5881-8804
Anupindi, Sudha A.

Gee, Michael S.

Trout, Andrew T.

Callahan, Michael J.
License Information

Text and Data Mining valid from 2019-07-26

Version of Record valid from 2019-07-26
More Information

Article History

Received: 25 March 2019

Revised: 13 June 2019

Accepted: 9 July 2019

First Online: 26 July 2019

Compliance with ethical standards

:

: Dr. Trout is a consultant for the Guerbet Group and has received royalties for authorship from the Reed Elsevier/Wolters Kluwer Publishing Group.

Document is current

Any future updates will be listed below